138 related articles for article (PubMed ID: 33936369)
1. Reduced circulating exosomal miR-382 predicts unfavorable outcome in non-small cell lung cancer.
Luo R; Liu H; Chen J
Int J Clin Exp Pathol; 2021; 14(4):469-474. PubMed ID: 33936369
[TBL] [Abstract][Full Text] [Related]
2. Serum exosomal miR-378 upregulation is associated with poor prognosis in non-small-cell lung cancer patients.
Zhang Y; Xu H
J Clin Lab Anal; 2020 Jun; 34(6):e23237. PubMed ID: 32061007
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of serum exosomal miR-216b predicts unfavorable prognosis in patients with non-small cell lung cancer.
Liu W; Liu J; Zhang Q; Wei L
Cancer Biomark; 2020; 27(1):113-120. PubMed ID: 31771047
[TBL] [Abstract][Full Text] [Related]
4. Early diagnostic and prognostic value of serum exosomal miR-1246 in non-small cell lung cancer.
Huang D; Qu D
Int J Clin Exp Pathol; 2020; 13(7):1601-1607. PubMed ID: 32782678
[TBL] [Abstract][Full Text] [Related]
5. Circulating exosomal microRNA-4497 as a potential biomarker for metastasis and prognosis in non-small-cell lung cancer.
Zheng B; Peng M; Gong J; Li C; Cheng H; Li Y; Tang Y
Exp Biol Med (Maywood); 2023 Aug; 248(16):1403-1413. PubMed ID: 37551102
[TBL] [Abstract][Full Text] [Related]
6. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Role of Circulating Exosomal miR-425-3p for the Response of NSCLC to Platinum-Based Chemotherapy.
Yuwen D; Ma Y; Wang D; Gao J; Li X; Xue W; Fan M; Xu Q; Shen Y; Shu Y
Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):163-173. PubMed ID: 30228154
[TBL] [Abstract][Full Text] [Related]
8. Identification of serum exosomal miR-148a as a novel prognostic biomarker for breast cancer.
Li D; Wang J; Ma LJ; Yang HB; Jing JF; Jia MM; Zhang XJ; Guo F; Gao JN
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7303-7309. PubMed ID: 32706068
[TBL] [Abstract][Full Text] [Related]
9. Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients.
Zhang Y; Zhang Y; Yin Y; Li S
Pathol Res Pract; 2019 Aug; 215(8):152466. PubMed ID: 31146974
[TBL] [Abstract][Full Text] [Related]
10. Circulating Exosomal miR-96 as a Novel Biomarker for Radioresistant Non-Small-Cell Lung Cancer.
Zheng Q; Ding H; Wang L; Yan Y; Wan Y; Yi Y; Tao L; Zhu C
J Oncol; 2021; 2021():5893981. PubMed ID: 33727921
[TBL] [Abstract][Full Text] [Related]
11. Expression of serum exosomal miR-23b-3p in non-small cell lung cancer and its diagnostic efficacy.
Wang J; Xue H; Zhu Z; Gao J; Zhao M; Ma Z
Oncol Lett; 2020 Oct; 20(4):30. PubMed ID: 32774503
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.
Zou SL; Chen YL; Ge ZZ; Qu YY; Cao Y; Kang ZX
Cancer Biomark; 2019; 26(1):69-77. PubMed ID: 31306108
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of Plasma Exosomal MicroRNA-451a as a Noninvasive Biomarker for Early Prediction of Recurrence and Prognosis of Non-Small Cell Lung Cancer.
Kanaoka R; Iinuma H; Dejima H; Sakai T; Uehara H; Matsutani N; Kawamura M
Oncology; 2018; 94(5):311-323. PubMed ID: 29533963
[TBL] [Abstract][Full Text] [Related]
14. Exosomal microRNA in plasma as a non-invasive biomarker for the recurrence of non-small cell lung cancer.
Dejima H; Iinuma H; Kanaoka R; Matsutani N; Kawamura M
Oncol Lett; 2017 Mar; 13(3):1256-1263. PubMed ID: 28454243
[TBL] [Abstract][Full Text] [Related]
15. Low serum exosomal miR-484 expression predicts unfavorable prognosis in ovarian cancer.
Zhang W; Su X; Li S; Liu Z; Wang Q; Zeng H
Cancer Biomark; 2020; 27(4):485-491. PubMed ID: 32065786
[TBL] [Abstract][Full Text] [Related]
16. Tumor-Derived Exosomal miRNAs as Diagnostic Biomarkers in Non-Small Cell Lung Cancer.
Zhang Z; Tang Y; Song X; Xie L; Zhao S; Song X
Front Oncol; 2020; 10():560025. PubMed ID: 33178588
[TBL] [Abstract][Full Text] [Related]
17. Low plasma miR-25 expression is a favorite prognosis factor in non-small cell lung cancer.
Zhang YL; Zhang ZL; Zhu XB; Xu L; Lu P; Xu M; Liu WJ; Zhang XY; Yao HM; Ye XW
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5251-5259. PubMed ID: 31298376
[TBL] [Abstract][Full Text] [Related]
18. Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.
Yang X; Zhang Q; Zhang M; Su W; Wang Z; Li Y; Zhang J; Beer DG; Yang S; Chen G
Int J Biol Sci; 2019; 15(8):1712-1722. PubMed ID: 31360113
[TBL] [Abstract][Full Text] [Related]
19. Serum Exosomal miR-1290 is a Potential Biomarker for Lung Adenocarcinoma.
Wu Y; Wei J; Zhang W; Xie M; Wang X; Xu J
Onco Targets Ther; 2020; 13():7809-7818. PubMed ID: 32801784
[TBL] [Abstract][Full Text] [Related]
20. Serum exosomal miR-182 upregulation predicts unfavorable prognosis of esophageal squamous cell carcinoma.
Qiu ML; Li X; Lin JB; Luo RG; Liu B; Feng Z
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5412-5418. PubMed ID: 32495876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
